Cargando…

Eight-years Egyptian experience of Boston type I keratoprosthesis following failed penetrating keratoplasty or ocular surface disease

PURPOSE: To evaluate the outcome and complications after implantation of the Boston type I keratoprosthesis (Kpro) in two groups of eyes. METHODS: We retrospectively reviewed records of 28 eyes with failed Penetrating keratoplasty (PKP) (Group A) and 31 eyes with severe ocular surface diseases who i...

Descripción completa

Detalles Bibliográficos
Autores principales: Othman, Ihab S., Gharieb, Hesham M., Ibrahim, Hani M. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375450/
https://www.ncbi.nlm.nih.gov/pubmed/35971487
http://dx.doi.org/10.4103/sjopt.sjopt_36_20
_version_ 1784767965205364736
author Othman, Ihab S.
Gharieb, Hesham M.
Ibrahim, Hani M. G.
author_facet Othman, Ihab S.
Gharieb, Hesham M.
Ibrahim, Hani M. G.
author_sort Othman, Ihab S.
collection PubMed
description PURPOSE: To evaluate the outcome and complications after implantation of the Boston type I keratoprosthesis (Kpro) in two groups of eyes. METHODS: We retrospectively reviewed records of 28 eyes with failed Penetrating keratoplasty (PKP) (Group A) and 31 eyes with severe ocular surface diseases who implanted Kpro. Follow-up was performed for a mean 37 months. Primary outcomes were Kpro retention and visual improvement, secondary outcomes included the occurrence of complications as endophthalmitis, retro-prosthesis membrane (RPM), intraocular pressure (IOP) abnormalities, posterior capsule opacification (PCO), graft thinning and extrusion. RESULTS: Visual improvement was achieved in 20 eyes in Group A, and in 19 eyes in Group B. In group A, the prosthesis was retained in 25 eyes, while prosthesis retention in Group B was in 26 eyes. Group A had higher rates of PCO, high IOP, soft IOP, and graft thinning. Group B had higher risk of RPM, and endophthalmitis. Two eyes in Group A, and Five eyes in Group B required redo procedure. CONCLUSION: The Boston Kpro type I is an effective procedure in eyes with high risk of keratoplasty failure and in severe ocular surface diseases, it has a high retention rate, higher in cases following failed PKP.
format Online
Article
Text
id pubmed-9375450
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-93754502022-08-14 Eight-years Egyptian experience of Boston type I keratoprosthesis following failed penetrating keratoplasty or ocular surface disease Othman, Ihab S. Gharieb, Hesham M. Ibrahim, Hani M. G. Saudi J Ophthalmol Original Article PURPOSE: To evaluate the outcome and complications after implantation of the Boston type I keratoprosthesis (Kpro) in two groups of eyes. METHODS: We retrospectively reviewed records of 28 eyes with failed Penetrating keratoplasty (PKP) (Group A) and 31 eyes with severe ocular surface diseases who implanted Kpro. Follow-up was performed for a mean 37 months. Primary outcomes were Kpro retention and visual improvement, secondary outcomes included the occurrence of complications as endophthalmitis, retro-prosthesis membrane (RPM), intraocular pressure (IOP) abnormalities, posterior capsule opacification (PCO), graft thinning and extrusion. RESULTS: Visual improvement was achieved in 20 eyes in Group A, and in 19 eyes in Group B. In group A, the prosthesis was retained in 25 eyes, while prosthesis retention in Group B was in 26 eyes. Group A had higher rates of PCO, high IOP, soft IOP, and graft thinning. Group B had higher risk of RPM, and endophthalmitis. Two eyes in Group A, and Five eyes in Group B required redo procedure. CONCLUSION: The Boston Kpro type I is an effective procedure in eyes with high risk of keratoplasty failure and in severe ocular surface diseases, it has a high retention rate, higher in cases following failed PKP. Wolters Kluwer - Medknow 2022-07-11 /pmc/articles/PMC9375450/ /pubmed/35971487 http://dx.doi.org/10.4103/sjopt.sjopt_36_20 Text en Copyright: © 2022 Saudi Journal of Ophthalmology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Othman, Ihab S.
Gharieb, Hesham M.
Ibrahim, Hani M. G.
Eight-years Egyptian experience of Boston type I keratoprosthesis following failed penetrating keratoplasty or ocular surface disease
title Eight-years Egyptian experience of Boston type I keratoprosthesis following failed penetrating keratoplasty or ocular surface disease
title_full Eight-years Egyptian experience of Boston type I keratoprosthesis following failed penetrating keratoplasty or ocular surface disease
title_fullStr Eight-years Egyptian experience of Boston type I keratoprosthesis following failed penetrating keratoplasty or ocular surface disease
title_full_unstemmed Eight-years Egyptian experience of Boston type I keratoprosthesis following failed penetrating keratoplasty or ocular surface disease
title_short Eight-years Egyptian experience of Boston type I keratoprosthesis following failed penetrating keratoplasty or ocular surface disease
title_sort eight-years egyptian experience of boston type i keratoprosthesis following failed penetrating keratoplasty or ocular surface disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375450/
https://www.ncbi.nlm.nih.gov/pubmed/35971487
http://dx.doi.org/10.4103/sjopt.sjopt_36_20
work_keys_str_mv AT othmanihabs eightyearsegyptianexperienceofbostontypeikeratoprosthesisfollowingfailedpenetratingkeratoplastyorocularsurfacedisease
AT ghariebheshamm eightyearsegyptianexperienceofbostontypeikeratoprosthesisfollowingfailedpenetratingkeratoplastyorocularsurfacedisease
AT ibrahimhanimg eightyearsegyptianexperienceofbostontypeikeratoprosthesisfollowingfailedpenetratingkeratoplastyorocularsurfacedisease